Xbrane Biopharma AB (XBRANE) — Defensive Interval Ratio

Latest as of December 2025: 685 days

Xbrane Biopharma AB (XBRANE) has a Defensive Interval Ratio of 685 days as of December 2025. Defensive assets of Skr98.89 Million (cash Skr86.59 Million, short-term investments Skr-, receivables Skr12.30 Million) cover 685 days of daily cash needs of Skr144.28K/day. Check Xbrane Biopharma AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

685 days
Days of operational coverage

Defensive Assets

Skr98.89 Million
Cash + ST Investments + Receivables

Daily Cash Need

Skr144.28K
Current Liabilities ÷ 365

Current Liabilities

Skr52.66 Million
SEK

Xbrane Biopharma AB Defensive Interval Ratio (2012–2025)

This chart shows how Xbrane Biopharma AB's Defensive Interval Ratio has evolved across 13 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 685 days, meaning defensive assets of Skr98.89 Million can fund 685 days of operations without new revenue. Also explore XBRANE shareholders equity momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Xbrane Biopharma AB (2012–2025)

The table below presents the year-by-year Defensive Interval Ratio for Xbrane Biopharma AB from 2012 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see XBRANE market cap overview.

Year DIR (days) Defensive Assets (SEK) Daily Cash Need Cash ST Investments Change (days)
2025 85 days Skr12.30 Million Skr144.28K/day Skr- Skr- ▼ -73 days
2024 158 days Skr232.68 Million Skr1.47 Million/day Skr- Skr- ▲ +78 days
2023 80 days Skr71.18 Million Skr894.68K/day Skr- Skr- ▲ +6 days
2022 73 days Skr47.46 Million Skr648.13K/day Skr- Skr- ▼ -10 days
2021 84 days Skr50.25 Million Skr601.83K/day Skr- Skr- ▼ -29 days
2020 113 days Skr58.37 Million Skr517.79K/day Skr- Skr- ▲ +97 days
2019 15 days Skr5.89 Million Skr382.51K/day Skr- Skr- ▼ -32 days
2018 47 days Skr20.92 Million Skr442.14K/day Skr- Skr- ▼ -117 days
2017 165 days Skr8.07 Million Skr49.02K/day Skr- Skr- ▼ -2196 days
2016 2360 days Skr38.05 Million Skr16.12K/day Skr31.34 Million Skr- ▲ +2330 days
2015 30 days Skr1.93 Million Skr64.12K/day Skr- Skr- ▼ -247 days
2014 277 days Skr296.57K Skr1.07K/day Skr- Skr- ▲ +107 days
2012 170 days Skr265.60K Skr1.56K/day Skr- Skr- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)